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Abstract
 
Cyclin D family members are cellular protooncogenes, and their viral homologues in the Ka-
posi’s sarcoma-associated herpesvirus (KSHV, human herpesvirus type 8 [HHV-8]) and the
closely related 
 
Herpesvirus saimiri 
 
have been implicated as putative cofactors of viral transforma-
tion and pathogenesis. KSHV is regularly found in Kaposi’s sarcoma and in the primary effu-
sion B cell lymphoma and Castleman’s disease associated with immunosuppression and AIDS.
 
H. saimiri
 
 strain C488 transforms human and marmoset T cells in vitro and causes polyclonal T
cell lymphoma in New World monkeys. The viral cyclins stimulate cell cycle progression of
quiescent fibroblasts, and they form active cyclin-dependent kinase (CDK)6 complexes of
broad substrate specificity that can resist and downregulate cellular CDK inhibitors. This study
shows that the viral cyclin of 
 
H. saimiri
 
 strain C488 is not required for viral replication, T cell
transformation, and pathogenicity in New World primates.
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Introduction
 
The rhadinoviruses 
 
Herpesvirus saimiri
 
 and Kaposi’s sarcoma
(KS)-associated herpesvirus (KSHV, human herpesvirus 8
[HHV-8]) both encode viral cyclin D homologues and
several other candidate viral oncogenes. Cyclin D family
members are known cellular protooncogenes (1, 2), and the
viral cyclin of 
 
H. saimiri
 
 (V-cyclin) and KSHV (K-cyclin)
have been implicated as putative cofactors of viral transfor-
mation and pathogenesis (3–5).
 
KSHV is almost invariably found in endemic and
AIDS-associated Kaposi’s sarcoma and in rare lymphopro-
liferative syndromes associated with immune suppression,
like primary effusion B cell lymphoma (PEL) and multi-
centric Castleman’s disease (MCD). Several candidate on-
cogenes and cofactors for viral transformation have been
identified, among them the KSHV homologues to cyclin
D (K-cyclin) and G protein–coupled receptors (GPCRs;
reference 6).
The viral cyclins stimulate cell cycle progression of quies-
cent fibroblasts, and they were shown to form active cyclin-
dependent kinase (CDK)6 complexes resistant to inhibition
by cellular CDK inhibitors (7). Interestingly, the K-cyclin is
latently expressed in KS tissues (8) and PEL cells (9). The
closely related 
 
H. saimiri
 
 transforms human and marmoset T
cells in vitro and causes polyclonal T cell lymphoma in
New World monkeys. The open reading frame (ORF)72 of
 
H. saimiri
 
 encodes the viral cyclin D homologue (V-cyclin;
reference 4), a 29-kD protein that is expressed in growth-
transformed marmoset T cell lines (5). Both 
 
H. saimiri
 
and KSHV cyclin D homologues bind and activate cellular
CDKs 2, 4, and 6. The most stable and active complexes
are formed with CDK6, and these complexes are resistant
to cellular CDK inhibitors p16
 
Ink4a
 
, p21
 
Cip1
 
, and p27
 
Kip1
 
,
and K-cyclin expression has even been shown to result in
p27
 
Kip1
 
 degradation. In addition, they can stimulate S phase
entry and cell growth of quiescent fibroblasts (3, 5, 7, 10,
11). The viral cyclin encoded by B lymphotropic murine
gammaherpesvirus 68 (MHV-68 M-cyclin) is expressed as a
lytic leaky-late or early-late transcript (12, 13). M-cyclin
acts as an oncogene when overexpressed in transgenic mice
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which then develop T cell lymphoma (13). On the other
hand, the M-cyclin has a restricted CDK preference, as it
binds only to CDK2 in a similar way to cyclin A, and this
binding is partially inhibited by p27
 
Kip1
 
 (14). Although
MHV-68 infection was reported to be associated with lym-
phoproliferative disease and lymphoma in aging mice (15),
tumor cell lines established from such lesions typically do
not harbor MHV-68 (16), and lymphocyte growth trans-
forming properties are absent in vitro (17). Thus, there is an
obvious contrast between an oncogenic phenotype in a
transgenic system and uncertain tumorigenicity of MHV-68
infection in mice.
In view of the uncertain role of rhadinoviral cyclins, we
studied the 
 
H. saimiri
 
 V-cyclin, as 
 
H. saimiri
 
 has a clearly
defined growth transforming and oncogenic phenotype in
New World primates. The V-cyclin gene was deleted from
the genome of 
 
H. saimiri
 
 strain C488, resulting in a replica-
tion competent virus. This recombinant virus showed that
the V-cyclin is not necessary for T cell transformation of
human and common marmoset lymphocytes in vitro, and
the virus remained oncogenic in 
 
Saguinus oedipus
 
 tamarins,
indistinguishable from the wild-type strain.
 
Materials and Methods
 
Cell Culture and Virus Propagation.
 
Owl monkey kidney
(OMK) cells (American Type Culture Collection, CRL1556),
cultivated in DMEM supplemented with 350 
 
m
 
g/ml glutamine,
100 
 
m
 
g/ml gentamycine, and 10% heat-inactivated FCS, were
used for the propagation of 
 
H. saimiri
 
.
 
 
 
Virus stocks were generated
by infection of confluent OMK cells seeded in 175-cm
 
2
 
 tissue cul-
ture flasks at low multiplicity. When lysis was complete, superna-
tants were cleared from cellular debris by centrifugation at 2,000 
 
g
 
for 15 min and cell-free supernatants were stored at 
 
2
 
80
 
8
 
C. For
virus titration, OMK cells were grown in 48-well plates and in-
fected with serial 10-fold dilutions (10
 
2
 
3
 
–10
 
2
 
7
 
) of 
 
H. saimiri
 
 C488
and C488
 
D
 
cyclin in 400 
 
m
 
l DMEM with supplements. Single step
growth curves for the analysis of virus replication kinetics were
done by infection of OMK cells (3 
 
3
 
 10
 
5
 
 cells seeded in a 25-cm
 
2
 
flask 2 d before infection) with 10
 
4
 
 tissue culture infectious parti-
cles (TCIPs) in 10 ml medium, corresponding to 0.01 TCIPs/cell.
Virus containing supernatant taken from subsequent days was ti-
trated by limiting dilution until lysis was complete
 
.
 
Construction of the Viral Deletion Mutant C488
 
D
 
cyclin.
 
The
ORF72 was deleted from the
 
 
 
H. saimiri
 
 
 
strain C488 genome by a
cosmid-based approach. All cloning procedures were performed
by standard methods. A 
 
KpnI-PinAI
 
 fragment including ORFs
71, 72, and the 3
 
9
 
 portion of ORF73 was subcloned from cosmid
Dc5 into pNEB193PIN (constructed by insertion of a PinAI
adapter into the HindIII site of pNEB193 (New England Biolabs,
Inc.). The complete ORF72 was deleted by PCR (Expand Long
Template Kit™; Roche Diagnostics) using oligonucleotides
5
 
9
 
-GGCGCGCCTCGAAATTCTGTAAATGGAC-3
 
9
 
 
 
and
 
 
 
5
 
9
 
-
CGTACGTTTGATGATGTCATTCTATGGGC-3
 
9
 
.
 
 
 
The mod-
ified 
 
KpnI-PinAI
 
 fragment lacking the ORF72 was verified by
DNA sequencing, reinserted into cosmid Dc5, and finally the
correct reinsertion was verified again by DNA sequencing. Nu-
cleotide sequences were determined with an ABI 377A auto-
mated sequencer (Applied Biosystems) using the Dye-Deoxy
Terminator Sequencing™ kit according to the manufacturer’s in-
structions (PerkinElmer). Recombinant virus was generated by li-
 
posome-mediated cotransfection (Lipofectamine
 
®
 
; Life Technol-
ogies) of a set of overlapping cosmids including the altered
cosmid Dc5
 
D
 
cyclin into permissive OMK cells (see Fig. 1). The
cosmids were linearized before transfection by restriction with
NotI; this also removed the pWE15 cloning vector, as two NotI
sites are flanking the BamHI site used to clone the viral DNA.
 
Detection of V-Cyclin Protein.
 
Confluent OMK cells in 25-
cm
 
2
 
 flasks were infected with 10
 
6
 
 TCIPs of C488 or
C488
 
D
 
cyclin virus or mock infected. Protein was extracted in ly-
sis buffer (150 mM NaCl, 2 mM EDTA, 50 mM Tris, and 1%
Triton X-100) when first signs of cytopathic effect (CPE) became
visible. 20 
 
m
 
g of total protein were separated on 15% PAGE gel
and blotted to polyvinylidine difluoride (PVDF) membrane. The
V-cyclin was detected using a 1:500 dilution of specific rabbit
polyclonal antiserum (a gift of J. Jung, New England Regional
Primate Research Center, Southborough, MA and 1:5,000 di-
luted peroxidase-conjugated anti–rabbit immunoglobulin with
the enhanced chemiluminescence (ECL) system (Amersham
Pharmacia Biotech).
 
In Vitro Transformation of Human and Marmoset Lymphocytes.
 
Mononuclear cells from heparin-preserved human umbilical cord
blood was purified by centrifugation in dextran separation me-
dium, common marmoset blood with Histopaque™ solution
(equal volumes of Histopaque™ 1.083 g/ml and 1.117 g/ml;
Sigma-Aldrich). The mononuclear cells were recovered, washed,
and
 
 
 
resuspended in lymphocyte growth medium (LGM; RPMI
medium with 10% FCS, 45% Panserin™ serum-free medium
[Pansystems], 350 
 
m
 
g/ml 
 
l
 
-glutamine, and 100 
 
m
 
g/ml gentamy-
cin). For the transformation of human T cells, LGM was supple-
mented with recombinant IL-2 (100 U/ml Aldesleukin [Pro-
leukin™; Chiron Corp.] or 20 U/ml human IL-2 [Roche
Diagnostics]). Lymphocytes were expanded for 2–3 d after isola-
tion by stimulation with 0.5–1 
 
m
 
g/ml phytohemagglutinin A.
3–5 
 
3
 
 10
 
6
 
 cells were then infected with 1 ml of 
 
H. saimiri
 
 C488
or mutant virus C488
 
D
 
cyclin (titer 
 
.
 
10
 
6
 
 TCIPs/ml) and culti-
vated as described above. The transformation of the resulting T
cell lines was assessed microscopically and by the observation of
accelerated growth compared with uninfected control cultures
that stopped growing after 4–6 wk. None of the uninfected con-
trols yielded a transformed T cell line.
 
Animal Experiments and Ex Vivo Culture.
 
Two cottontop
tamarins (
 
S. oedipus
 
; R224 and B214) were infected intravenously
with 10
 
6
 
 TCIPs of C488
 
D
 
cyclin, and one control animal (B236)
received the same dose of oncogenic C488 wild-type virus. As
oncogenic 
 
H. saimiri
 
 strain C488 consistently showed a lethal
phenotype in this species, larger numbers of animals were not
considered due to ethical reasons. The study had been approved
by the Institutional Animal Care and Use Committee and was
performed according to governmental regulations with purpose
bred, healthy adult cottontop tamarins at the Biomedical Pri-
mate Research Center (Rijswijk, The Netherlands). They were
housed in separate cages and received a standard monkey diet and
drinking water ad libitum. Blood samples were taken prior infec-
tion, at weekly intervals, and before necropsy, to expand T lym-
phoma cells and reisolate virus by cocultivation on OMK cells.
The C488
 
D
 
cyclin-infected animals died or were killed on days
14 and 16 after infection, the control animal died on day 15, and
necropsy was performed. Single cell suspensions were prepared
from fresh liver, spleen, kidney, thymus, and lymph node tissue
and cultured in LGM without additional growth factors. In addi-
tion, tissues were fixed in formalin and stained with hematoxylin
and eosin, and for immunohistochemistry additionally with anti-
bodies specific for CD3 (Dako) and CD20 (Dako) and detected 
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with alkaline phosphatase–coupled avidin–biotin complex sec-
ondary reagents.
 
Detection of Viral DNA.
 
Virus-containing supernatant from
completely lysed cultures was harvested by centrifugation, and
the pelleted virions were lysed in 100 
 
m
 
l of PCR buffer contain-
ing 100 
 
m
 
g/ml proteinase K (Roche Diagnostics) and 0.5%
Tween 20 for 1 h at 56
 
8
 
C, then the proteinase K was heat-inacti-
vated for 15 min at 95
 
8
 
C. Alternatively, 2 
 
3
 
 10
 
5
 
 cells were lysed
under the same conditions. An aliquot of 2–4 
 
m
 
l was used for
PCR analysis.
The status of viral DNA in the transformed cell lines was ana-
lyzed by PCR and Southern blotting. PCR analysis was carried
out in 25-
 
m
 
l reaction volumes, containing 2 
 
m
 
l of template
DNA, 0.2 mM dNTP, 0.4 
 
m
 
M of each primer, and 2.5 U of
AmpliTaq polymerase in 1
 
3
 
 AmpliTaq buffer (PerkinElmer).
PCR conditions were as follows: a 5-min denaturation at 95
 
8
 
C,
29 cycles of 30 s at 95
 
8
 
C, 30 s at 56
 
8
 
C, and 1 min at 70
 
8
 
C; a
4-min extension at 70
 
8
 
C; and a 4
 
8
 
C hold. The following primer
pairs specific for the respective ORFs were used for the analy-
sis: StpC/Tip, 5
 
9
 
-GTAGTAAACTAAGAGCAAAGCAAGC-3
 
9
 
and 5
 
9
 
-GTACAAGCTGTTCAAGTTTGTTAGC-3
 
9
 
; ORF3,
5
 
9
 
-CACAACACTGGTATGTACCAATG-3
 
9
 
 and 5
 
9
 
-CTGTG-
GAGGTAATGCAGATAC-3
 
9
 
; ORF75, 59-TGGCTGCTAA-
CAGGCATGG-39 and 59-AGCACGTTGCCCGAGATTG-39;
V-cyclin a61=59-CTAAAAATGCAGCATCGTCACC-39  and
59-TGCGTTAGACAAATATCCC-39.
For Southern blotting, 20 mg of total DNA were digested with
SstI or PstI and electrophoresed on 1% agarose gels. The DNA
was transferred to a nylon membrane (Hybond N; Amersham
Pharmacia Biotech) and hybridized with a DNA probe that was
random-labeled with [a-32P]dATP. This 1.9-kb probe specific
for ORFs 71 and 72 was amplified by PCR from cosmid 40
(primers: 59-TGCGTTAGACAAATATCCC-39  and 59-CTA-
AAAATGCAGCATCGTCACC-39, conditions as above) and
purified from a 1% agarose gel.
RNA and cDNA Analysis. Total RNA was prepared by acid
guanidinium thiocyanate-phenol-chloroform extraction. 5 mg
RNA were treated with RNase-free DNaseI (Roche-Diagnos-
tics) in 13 DNaseI buffer for 30 min, followed by heat inactiva-
tion at 708C for 10 min. Then first strand cDNA was synthesized
with random hexamer and oligo-dT primers and Superscript II
reverse transcriptase (GIBCO BRL). RNA complementary to
the cDNA was then removed by addition of 2 U RNaseH (MBI
Fermentas) and incubation for 20 min at 378C. An identical sam-
ple was prepared in parallel where the reverse transcriptase was
omitted from the reaction mixture (2RT control sample). 2 ml
of the reactions were used for reverse transcription (RT)-PCR
analysis (as above except that 40 cycles of 958C, 528C, and 708C
were done). Primers were specific for the following ORFs:
NH2-terminal ORF73, 73RT5, 59-CACACTCTGCGTTCT-
GAGTGC-39 and 73RT3, 59-AACGTTGGGCACTTGGTC-
CTG-39, amplification product 962 bp; COOH-terminal
ORF73, 73ns, 59-CTATGGGCAAGCTTTTGC-39 and A61,
59-CTAAAAATGCAGCATCGTCACC-39, amplification pro-
duct 396 bp; V-cyclin 73RC3, 59-CCCTAGATCTGCTA-
AATTACAAGC-39 and 71RT, 59-TGCGTTAGACAAA-
TATCCC-39 amplified products of 1,060 and 265 bp,
respectively; ORF71, 59-TCGAAATTCTGTAAATGGAC-39
and 71RT, 59-TGCGTTAGACAAATATCCC-39, amplifica-
tion product size 190 bp; b-Actin ACT5, 59-CGG-
GAAATCGTGCGTGACAT-39 and ACT3, 59-GAAC-
TTTGGGGGATGCTCGC-39, amplification product size
587 bp.
Flow Cytometry and Cell Cycle Analysis. Transformed human
and simian T cells were analyzed by flow cytometry (FACSCali-
bur™; Becton Dickinson) with directly labeled monoclonal anti-
bodies specific against B and T cell surface epitopes (Cy-Chrome
or phycoerythrin conjugated): CD2 (RPA-2.10; BD PharMin-
gen), CD3e (SP34; BD PharMingen), CD3 (Leu-4; Becton
Dickinson), CD4 (Leu-3a SK3; Becton Dickinson) CD8 (RPA-
T8; BD PharMingen), CD20 (Leu16 L27; Becton Dickinson),
HLA-DR (L243; Becton Dickinson), isotype-matched control
antibodies (Becton Dickinson/BD PharMingen).
Results and Discussion
The complete V-cyclin gene was precisely deleted from
cosmid-cloned H. saimiri strain C488 DNA by subcloning
and PCR. Recombinant H. saimiri C488Dcyclin was gen-
erated by homologous recombination after transfection of
overlapping cosmids into permissive OMKs cells (Fig. 1 A).
Absence of the V-cyclin gene was verified by PCR and
Southern blotting, and absence of protein expression by
Western blotting from infected OMK cells (Fig. 1 B). Lytic
viral replication in OMK cells was comparable to wild-type
virus even when infection started at a low multiplicity of
0.01 TCIPs per cell, and endpoint titers of both wild-type
and recombinant virus were between 106 and 107 TCIPs/
ml in three independent experiments.
H. saimiri C488 and related strains are distinguished by
their ability to transform human primary T cells to perma-
nent antigen-independent growth (18, 19). In vitro trans-
formation assays were performed with 3–5 3 106 primary
human cord blood lymphocytes (CBLs) and Callithrix jac-
chus PBMCs from independent donors. Limiting dilution
of lymphocytes for transformation assays is not feasible
due to the specific growth requirements of H. saimiri–
Figure 1. V-cyclin transcript mapping and recombinant virus. (A)
Construction of recombinant virus C488Dcyclin from five overlapping
cosmids 331, 261, 290, 336, and Dc5Dcyclin. (A) KpnI-PinAI fragment
from cosmid Dc5 was subcloned into pNEB193PIN, the ORF72 deleted
by PCR, and the fragment reinserted into the cosmid. Recombinant virus
was generated by cotransfection of the overlapping linearized cosmids into
permissive OMK cells. (C) Absence of 29 kD V-cyclin protein expression
in OMK cells infected with recombinant virus compared with parent
strain C488. M, marker; UI, uninfected; WT C488, wild-type infected;
DEL, C488Dcyclin infected (polyclonal antibody was a gift of J. Jung).640 Herpesvirus saimiri V-Cyclin Is Not Required for Pathogenesis
transformed lymphocytes (19, 20). In these assays, the
C488Dcyclin mutant-transformed human and simian lym-
phocytes to T cell lines like the C488 wild-type virus (Ta-
ble I). Thus, the V-cyclin is not required for in vitro trans-
formation of human and common marmosets lymphocytes
by H. saimiri strain C488.
However, in vitro transformation not always parallels in
vivo pathogenicity (21; for a review, see reference 22).
Two S. oedipus tamarins (R224 and B214) were therefore
infected intravenously with 106 TCIPs of C488Dcyclin,
and a control animal (B236) received the equivalent dose of
oncogenic C488 wild-type virus. Larger numbers of ani-
mals were considered unnecessary, as oncogenic H. saimiri
strains consistently have a lethal phenotype in this species.
The C488Dcyclin infected animals became symptomatic
and died or were killed on days 15 and 16 after infection,
and the control animal died on day 15. Necropsy was per-
formed and macroscopic examination of tissues revealed
enlarged hyperemic lymph nodes, and white infiltrations in
kidneys. Histological examination of various tissues showed
infiltration of blast-like lymphoid cells that was consistent
with acute disseminated CD31 T cell lymphoma (Fig. 2
A). Single cell suspensions were prepared from liver,
spleen, kidney, thymus, and lymph nodes, and at least four
independent lymphocytic cell lines growing without IL-2
were established from different tissues of each animal. Flow
cytometry analysis of the tumor-derived cell lines revealed
a phenotype of CD3 and CD4 and/or CD8-positive T
Table I. Transformation by H. saimiri C488Dcyclin In Vitro and 
Pathogenesis in Infected Cottontop Tamarins
Virus Species
In vitro
transformation
experiments
(pos./total)
Pathogenesis
(survival time 
in days)
C488 Human CBL 8/8 na
C. jacchus 9/10 nd
S. oedipus nd 15
C488Dcyclin Human CBL 8/8 na
C. jacchus 5/5 nd
S. oedipus nd 15, 16
Transformation by recombinant viruses in vitro and pathogenesis in
infected cottontop tamarins. Results from in vitro transformation
experiments performed with human CBLs (eight different donors), and
PBMCs from C. jacchus (five donors). Cells were infected in parallel
with  H. saimiri C488 or C488Dcyclin; the number of successful
transformation experiments is shown. Pathogenesis was studied in
cottontop tamarins (S. oedipus). Two S. oedipus tamarins were infected
with C488Dcyclin (animals R224 and B214), and one animal (B236)
received the wild-type positive control strain C488. pos., positive; na,
not applicable; nd, not done.
Figure 2. Animal experiments and ex vivo culture. (A) Histology from C488Dcyclin (R224) and C488 (B236) infected monkeys. Both show infiltra-
tion of liver tissue with large numbers of blast-like cells. Immunohistochemistry revealed that almost all the infiltrating cells stained positive for CD3. HE,
hematoxylin and eosin stain. (B) Analysis of viral genome in cell lines established from diseased cottontop tamarins. Southern blot with a 32P-labeled
probe spanning viral ORFs 71 and 72 shows the expected fragment pattern and absence of wild-type C488 virus in C488Dcyclin mutant. Cell lines es-
tablished from animal B214, R224, and B236, respectively. (C) Analysis of cell lines established from diseased cottontop tamarins. V-cyclin: PCR per-
formed with oligonucleotide primers flanking the V-cyclin deletion show expected amplification products of 629 or 1413 bp in animals infected with
C488Dcyclin (B214, R224) or C488 (B236), respectively. ORF3175: multiplexed PCR for the detection of two reading frames from the left and right
end of the H. saimiri genome. H2O, negative control; M, marker.641 Ensser et al. Brief Definitive Report
cells, along with high expression of MHC class II, CD25,
CD80, and CD86 (not shown). All cell lines were harbor-
ing the respective viral genome as shown by Southern blot-
ting (Fig. 2 B). The absence of the deleted V-cyclin gene
and of wild-type virus was also shown by PCR (Fig. 2 C).
In summary, the H. saimiri V-cyclin homologue is also not
contributing to the pathogenicity by this oncogenic rhadi-
novirus. The transcription of the H. saimiri V-cyclin in
simian and latently infected human T cells was investigated
by Northern blot analysis, but no transcripts were found.
As there are no available specific and sensitive reagents,
protein expression of the ORF73 and ORF71 could not be
studied. However, a specific spliced mRNA that can en-
code ORFs 73, 72, and 71 was detectable by RT-PCR
and ribonuclease protection assays (RPA; unpublished
data). Sensitive RT-PCR found no evidence for expression
of additional spliced mRNAs that would encode ORF72
and 71 only, and which had been found in KSHV-infected
cells (23–25). As the V-cyclin is encoded by a tricistronic
transcript, RT-PCR for the flanking ORFs 71 and 73 was
performed, demonstrating that transcription of these genes
still occurs in the deletion virus infected or transformed
cells (Fig. 3).
Although it was shown that the MHV-68 M-cyclin is
dispensable for viral replication and pathogenicity in im-
munodeficient mice and that it is necessary for efficient re-
activation from latency (12, 26), this model does not allow
to address the question of oncogenesis and transformation.
Pathogenesis of this recombinant virus was assessed in im-
mune-deficient SCID mice not having lymphocytes, thus
lymphoma induction can not be studied (12, 26). Most
likely, though not defined precisely, death results of over-
whelming lytic viral replication, and associated cell destruc-
tion. Even from lymphomas occasionally observed in long-
term infected mice (15), tumor cells harboring MHV-68
are only infrequently cultivated (16). However, after in-
duction of B- or T cell lymphoma in immune competent
cottontop tamarins by Epstein-Barr virus or H. saimiri, re-
spectively, growth-transformed tumor-derived cell lines
harboring the transforming virus can be regularly ex-
panded.
In conclusion, the data show that the V-cyclin of H.
saimiri is dispensable for viral replication, transformation of
simian or human lymphocytes in vitro, and pathogenesis in
cottontop tamarins in vivo. Remarkably, experiments in
vitro had lead to speculations on the viral cyclins as putative
oncogenes or cofactors for transformation (3, 5, 7, 13). The
finding that the V-cyclin of H. saimiri has no oncogenic
properties in the background of the viral genome stresses
the importance of studying viral genes in their original ge-
netic context and shows the limitations when isolated viral
genes are overexpressed. Nevertheless, the viral cyclin
genes may be relevant in the persistently infected natural
host, where they could contribute to improved survival
and spread of latently infected cells. It does not exclude im-
plications on the AIDS-associated malignancies associated
with the closely related KSHV, where analogous studies are
not possible due to a lack of permissive systems and animal
models for pathogenesis.
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